You are here

  • Home
  • Archive
  • Volume 14, Issue 3
  • Adjuvant Wilms’ tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium

Citation Tools

Article menu
Paediatrics
Protocol
Adjuvant Wilms’ tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Van Genechten T, De Laere M, Van den Bossche J, et al
Adjuvant Wilms’ tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium
BMJ Open 2024;14:e077613. doi: 10.1136/bmjopen-2023-077613